Management of Hypertension and Hypotension in the Emergency Department - PowerPoint PPT Presentation

About This Presentation
Title:

Management of Hypertension and Hypotension in the Emergency Department

Description:

Management of Hypertension and Hypotension in the Emergency Department Hypertension How do we manage Hypertension in the ER?? Hypertension Management in the ED ... – PowerPoint PPT presentation

Number of Views:2661
Avg rating:3.0/5.0
Slides: 80
Provided by: phdresCar
Category:

less

Transcript and Presenter's Notes

Title: Management of Hypertension and Hypotension in the Emergency Department


1
Management of Hypertension and Hypotension in the
Emergency Department
2
Hypertension
  • How do we manage Hypertension in the ER??

3
Hypertension Management in the ED
  • Annual Census 78,000 patients
  • Approximately 215 patients per day
  • 40 to 50 have elevated BP readings upon
    admission to the ED
  • That is roughly 39,000 patients/yr with elevated
    blood pressure readings in the ER.

4
  • First Step
  • Categorize Types of
  • Hypertension

5
Four Categories of Hypertension
  • - Hypertensive Emergency
  • - Hypertensive Urgency
  • - Acute Hypertensive Episode
  • - Transient Hypertension

6
  • What is a Hypertensive
  • Emergency?

7
Hypertensive Emergency
  • - A relative increase in blood pressure from
    baseline combined with Target Organ Dysfunction
    (TOD)
  • No Defined Pressure Measurement
  • Target Organ Damage is evident
  • Also known as Hypertensive Crisis or Malignant
    Hypertension
  • The MOST Serious form of hypertension

8
  • How do we define
  • Target Organ Dysfunction
  • ???

9
Target Organ Dysfunction
  • Evidence of Damage or Injury to Target
    Organs such as the Heart, Brain, Lungs, Kidneys,
    or Aorta.

10
Examples of Target Organ Dysfunction
  • Acute MI/ Unstable Angina
  • CVA
  • ICH / Subarachnoid Hemorrhage
  • CHF
  • Aortic Dissection
  • Acute Renal Failure
  • Hypertensive Encephalopathy

11
  • How do we determine if
  • Target Organ Dysfunction
  • is present?

12
Evaluation for Target Organ Dysfunction
  • 1. EKG (Evaluation for ST elevation or
    depression, new T-wave inversions, LVH, or new
    Left BBB)
  • CXR (CHF/pulmonary edema, cardiomegaly, widened
    mediastinum)
  • UA or urine dip (looking for proteinuria, red
    cells, or red cell casts)
  • Chem 8 (elevated BUN/CR indicating acute renal
    insufficiency or failure, look for other
    etiologies causing mental status changes, like
    hypoglycemia)
  • Neurological Exam (Evaluate for lateralizing
    signs and symptoms)
  • Funduscopic Exam (looking for papilledema or
    hemorrhages)
  • 7. CT Head (only if neurological findings
    are suspicious for acute CVA)

13
  • Diagnosis and Management
  • of
  • Hypertensive Emergency

14
Hypertensive Encephalopathy
  • Pathophysiology
  • - Loss of Cerebral Autoregulation of blood flow
    resulting in hyperperfusion of the brain, loss of
    integrity of the blood brain barrier, and
    vascular necrosis.
  • Loss of Autoregulation occurs at a constant
    cerebral blood flow of above MAP 150 to 160 mmHg.
  • Acute Onset
  • Reversible

15
Hypertensive Encephalopathy
  • Symptoms
  • Headache, Nausea/Vomiting, Lethargy,
  • Confusion, Lateralizing neurological symptoms
  • that are not often in an anatomical
    distribution.
  • Signs
  • Papilledema, Retinal Hemorrhages
  • Decreased level of consciousness, Coma
  • Focal neurological findings

16
Management of Hypertensive Encephalopathy
  • Reduce Mean Arterial Pressure (MAP) by 20 to 25
    (T.397) and do not exceed this within first 30 to
    60 min.
  • Rosen recommends reduction of 30 to 40 (R.1759)
  • MAP 1/3(SBP-DBP) DBP
  • Treatment Reduces vasospasm that occurs at these
    high pressures
  • Avoid excessive BP reduction to prevent
    hypoperfusion of the brain and further cerebral
    ischemia

17
Management of Hypertensive Encephalopathy
  • - Nitroprusside is the agent of choice (T.397)
    and (R.1759)
  • - Nitroglycerin and Labetalol have been
    used successfully, but have not replaced
    Nitroprusside

18
  • Management of Ischemic
  • CVA

19
Ischemic CVA
  • Pathophysiology
  • Elevated Blood Pressure can be the cause of
    the central nervous system event, OR, it may be a
    normal physiologic response (Cushings Reflex)

20
Ischemic CVA Management
  • Elevated blood pressure is usually a physiologic
    response to the stroke itself and NOT the
    immediate cause
  • This elevation of blood pressure maintains
    cerebral perfusion to viable but edematous tissue
    surrounding the ischemic area.
  • Most embolic or thrombotic strokes do NOT have
    substantial BP elevations and do not need
    aggressive therapy

21
Ischemic CVA Management
  • Management VERY CONTROVERSIAL!
  • Recent Trends leans towards NOT treating
    hypertension in the presence of a Cerebrovascular
    Accident (thrombotic or embolic) unless Diastolic
    Blood Pressure exceeds 140mmHg.

22
Ischemic CVA Management
  • Tintinelli Favors lowering MAP (mean arterial
    pressure) by 20.
  • Recommends IV Labetalol in small doses of 5mg
    increments IF Diastolic Blood Pressure is higher
    than 140 mmHg.
  • (T. 398)

23
Ischemic CVA Managment
  • Rosen In most cases, recommends no treatment of
    Hypertension in CVA patients.
  • (p. 1760).
  • - However, the author does recommend treating
    HTN if diastolic blood pressure is greater than
    140 mmHg.

24
  • Management of
  • Hemorrhagic CVA

25
Causes of Hemorrhagic CVA
  • Hypertensive Vascular Disease
  • Arteriovenous Anomalies (AVM)
  • Arterial Aneurysms
  • Tumors
  • Trauma

26
Hemorrhagic CVA Management
  • Hypertension associated with hemorrhagic stroke
    is usually transitory and the result of increased
    intracranial pressure and irritation of the
    Autonomic Nervous System

27
Hemorrhagic CVA Management
  • Hemorrhagic CVAs commonly results in a profound
    reactive rise in blood pressure
  • Management is CONTROVERSIAL.
  • Subarachnoid Hemorrhage oral nimodipine
    (nimotop) 60mg po q 4 hours to reverse vasospasm.
    (T.398)
  • Nicardipine 2mg IV boluses followed by an IV
    infusion of 4 to 15 mg/hr is used by some to
    treat Subarachnoid Hemorrhage. (T.398)

28
  • Management of CHF/
  • Pulmonary Edema

29
Congestive Heart Failure / Pulmonary Edema
  • Pathophysiology
  • Increased Afterload with decreased Cardiac
    Output

30
CHF / Pulmonary Edema
  • Symptoms
  • Shortness of Breath, Cough, Chest Pain
  • Lower Extremity Swelling
  • Signs
  • Jugular Venous Distension, Rales, S3 Gallop
  • Hepatomegaly, Pedal Edema

31
CHF / Pulmonary Edema Management in the ED
  • Nitroprusside or IV Nitroglycerin (T. 398)
  • Rosen May start with Nitroglycerin, but
    Nitroprusside is agent of choice if Pulmonary
    Edema is present. (R. 1760)
  • Attempt treatment of CHF initially with standard
    agents (Lasix,sublingual NTG, morphine), as these
    often lower blood pressure, but resort to
    Nitroprusside if necessary (R. 1761)

32
  • Management of Acute
  • Coronary Syndrome/
  • Acute MI

33
Acute Coronary Syndrome / Acute MI
  • Pathophysiology
  • - Increased afterload, cardiac workload,
    and myocardial oxygen demand
  • - Decreased coronary artery blood flow

34
Acute Coronary Syndrome / Acute MI
  • Symptoms
  • Chest Pain, Nausea / Vomiting, Diaphoresis,
  • Shortness of Breath
  • Signs
  • Congestive Heart Failure Signs,
  • S4 Gallop
  • (due to decreased ventricular compliance)
  • Few physical findings in many patients
  • Clinical History is very Important

35
Acute Coronary Syndrome/Acute MI
  • Immediate Blood Pressure reduction is
    indicated to prevent Myocardial Damage
  • No specific Defined BP target
  • Tailor treatment to symptom relief
  • (T. 398)

36
Acute Coronary Syndrome / Acute MI
  • Management
  • Nitroglycerin IV or Sublingual (T. 398)
  • Nitroprusside (T. 398)
  • Beta Blockers (Esmolol,Lopressor) (T.
    356-357)
  • Nitroglycerin is Drug of Choice (R. 1761)

37
  • Dissection of
  • Thoracic Aorta

38
Dissection of Thoracic Aorta
  • Pathophysiology
  • - Atherosclerotic Vascular Disease, Chronic
    Hypertension, increased shearing force on the
    thoracic aorta, leading to intimal tear.
  • - 50 begin in ascending aorta
  • - 30 at aortic arch
  • - 20 in descending aorta (R.1762-3)

39
Dissection of Thoracic Aorta
  • Symptoms
  • Chest pain radiating to the back (classic
    presentation)
  • Neurological Symptoms (carotid artery dissection)
  • Angina (coronary artery dissection)
  • Shortness of breath (aortic insufficiency,
    cardiac tamponade)
  • Signs
  • - Differential Blood Pressure (in UE)
  • Bruit (interscapular)
  • Neurological Deficits
  • Acute Cardiac Tamponade (rare)

40
Dissection of Thoracic Aorta
  • Management
  • Medications with negative inotropic effects
    (beta-blockers) MUST be given FIRST. (reduces
    shearing force)
  • Vasodilators (nitroprusside) may be added for
    further antihypertensive treatment after
    administration of a negative inotropic agent.

41
Dissection of Thoracic Aorta
  • Optimal Blood Pressure in these patients is
    undefined and must be tailored for each patient,
    however,
  • SBP of 120-130mmHg may be a intial starting
    point. (T.408)

42
  • Acute Renal Failure

43
Acute Renal Failure
  • Pathophysiology
  • Hypertensive Glomerulonephropathy, Acute Tubular
    Necrosis (ATN)
  • - Worsening renal function in the setting of
    severe hypertension with elevation of BUN/CR,
    proteinuria, or the presence of red cells and red
    cell casts in the urine.

44
Acute Renal Failure
  • Symptoms
  • - Many times there are few actual symptoms
  • Facial or Peripheral Edema due to fluid overload
    or proteinuria may be present, shortness of
    breath
  • Signs
  • Few findings unless edematous
  • Pulmonary Edema

45
Acute Renal Failure
  • Management
  • Nitroprusside is agent of choice (T.398)
  • Dialysis (as needed)
  • Rosen Lasix to enhance Sodium excretion Also
    recommends Nitroprusside or Nifedipine (R.1761)
  • Nitroglycerin is also a good agent in this
    setting since it is hepatically metabolized and
    gastrointestinally excreted.

46
  • Pheochromocytoma

47
Pheochromocytoma
  • Pathophysiology
  • - Alpha and Beta stimulation of the
    cardiovascular system due to adrenergic excess
    states

48
Pheochromocytoma
  • Symptoms
  • Episodic Headaches, flushing, tremor,
    diaphoresis, diarrhea, hyperactivity, and
    palpitations
  • Signs
  • Tachycardia, tachypnea, tremor, hyperdynamic
    state (high output CHF)

49
Pheochromocytoma
  • Management
  • Alpha Blocker FIRST, followed by a Beta Blocker
  • Phentolamine (alpha) Esmolol (beta)
  • Labetalol IV (combined alpha and beta blockade)

50
  • Toxemia of Pregnancy
  • Eclampsia/Pre-Eclampsia

51
Toxemia of Pregnancy
  • Pathophysiology
  • Systemic arterial vasoconstriction (including
    placental, leading to decreased uterine blood
    flow).
  • Defined as SBP 140/90 mmHg or greater, OR a 20
    mmHg rise in SBP or 10 mmHg rise in DBP
    from baseline and evidence of HELLP Syndrome

52
Toxemia of Pregnancy
  • Symptoms
  • Lower extremity swelling, headache, confusion,
    seizures, coma
  • Signs
  • Edema, hyperreflexia, elevation of blood
    pressure related to baseline BP prior to
    pregnancy (elevation may be mild 125/75)

53
Toxemia of Pregnancy
  • Management
  • IV Magnesium Sulfate, Hydralazine.
  • May also use nifedipine or labetalol (R.1762)
  • Delivery of Fetus is definitive treatment of
    pre-eclampsia

54
Summary of Medications used for Hypertensive
Emergencies
  • - Intravenous Nitroglycerin
  • Start at 0.2 to 0.4 mcg/kg/min (10 to 30
    mcg/min) and rapidly increase in 5 to10 mcg/min
    increments. Titrate to BP and symptomatic
    improvement. (T.369)
  • - Nitroprusside
  • Start 0.3 mcg/kg/min and titrate up every 5
    to 10 minutes based on BP and clinical response.
    (T.369)
  • - Esmolol 500 mcg/kg initial bolus over 1
    minute, then start infusion at 50 to 150
    mcg/kg/min (T.408)
  • - Metoprolol (Lopressor) 5mg IV every 2 minutes
    for a total of 3 doses, then start infusion at 2
    to 5 mg/hr. (T.408)

55
Summary of Medications used for Hypertensive
Emergencies
  • - Labetalol 20mg IV initial dose, with repeat
    doses of 40mg to 80mg every 10 minutes to reach
    desired effect or max dose 300mg. (T. 408)
  • Nicardipine 2mg IV boluses followed by an IV
    infusion of 4 to 15 mg/hr
  • Magnesium Sulfate IV 4 to 6 grams over 15
    minutes, followed by IV infusion of 1 to 2
    grams/hour
  • Hydralazine 10 to 20mg IV

56
  • What is a Hypertensive
  • Urgency??

57
Hypertensive Urgency
  • - A relative increase in blood pressure from
    baseline WITHOUT current evidence of TOD, but
    potential of progression to TOD is HIGH.
  • - Increased likelihood when pre-existing
    conditions are present
  • (renal insufficiency, CAD, CHF)

58
Hypertensive Urgency
  • Current recommendation is the gradual reduction
    of blood pressure within 24 to 48 hours by using
    oral antihypertensive agents
  • Non-compliance is a common cause, therefore,
    restarting a current regimen of blood pressure
    medication is appropriate
  • Making needed changes to current blood pressure
    medication regimens is also appropriate
  • Follow-up within 24 hours should be arranged with
    Primary Care Physician

59
Oral Regimens for Treatment of
Hypertensive Urgency in the ED
  • (Tintinelli pg. 402)
  • Clonidine 0.1 to 0.2mg PO, repeat 0.1mg q hour
    to desired BP reduction or max of 0.7mg.
  • Labetalol 200 to 400mg PO, repeat every 2 to 3
    hours
  • Captopril 25mg PO
  • Losartan 50mg PO

60
  • What is an Acute
  • Hypertensive Episode?

61
Acute Hypertensive Episode
  • Elevation of Blood Pressure relative to
    baseline, but WITHOUT evidence of acute OR
    impending Target Organ Dysfunction (TOD)

62
Management of Acute Hypertensive Episode
  • Paucity of evidence that acute intervention in ED
    is warranted for Hypertensive Episode
  • Complications can occur in acute treatment of
    patients with chronically elevated blood pressure
  • If HTN is newly diagnosed in the ER, patients
    should be referred to Primary Care physician for
    evaluation and initiation of therapy within 24 to
    48 hours
  • Again, restarting prior blood pressure medication
    regimens or adjusting doses is appropriate for
    patients with previously diagnosed hypertension.

63
  • What is Transient
  • Hypertension??

64
Treatment of Transient Hypertension
  • Transient HTN occurs in association with other
    conditions like anxiety, alcohol withdrawal
    syndromes, toxicological substances, and sudden
    cessation of medications)
  • Treatment is aimed at underlying cause
  • White-Coat Hypertension
  • Single encounter in ED does not warrant diagnosis
    of HTN or treatment of HTN
  • Follow-up with Primary Care Physician

65
  • SWITCHING GEARS

66
  • Hypotension/Shock
  • Management in the ED

67
Hypotension/Shock
  • Types of Shock
  • - Hypovolemic
  • (inadequate circulating volume)
  • - Cardiogenic
  • (inadequate pump function)
  • - Distributive
  • (peripheral vasodilitation)
  • - Obstructive
  • (extra-cardiac obstruction of blood
  • flow)

68
Hypotension/Shock Goals of Management
  • 1. Determine Cause
  • - Usually very apparent
  • - Can be subtle
  • - No single Vital Sign that is diagnostic of
    Shock
  • - Initial Therapy guided by clinical findings

69
Management of Hypotension/Shock
  • 2. Evaluate Signs and Symptoms
  • - Tachycardia
  • - Decreased Urine Output
  • - Cool, Mottled Skin
  • - Cyanosis
  • - Confusion

70
Hypotension/Shock Goals of Resuscitation
  • ABCs
  • A- Secure Airway (intubate if needed)
  • B- Insure oxygenation and ventillation
  • C- Provide Hemodynamic Stabilization
    (correction of hypotension based on etiology)

71
Resuscitation
  • Initiate Fluid Therapy
  • 0.25 to 0.5 Liters of Normal Saline (NS) or
    similar isotonic crystalloid should be
    administered every 5 to 10 minutes as needed for
    correction of hypotension

72
Rapid Fluid Administration
  • It is not unusual for a patient to require 4 to
    6 Liters of fluid in the initial phase of
    resuscitation.

73
Goal of Fluid Resusciation
  • Stabilization of pts mentation
  • Improvement in Blood Pressure
  • Reduction of Pulse Rate
  • Improved Skin Perfusion
  • Urine Output gt 30ml per hour

74
Inotropic Support
  • If NO response to initial fluid infusion of 3
    to 4 L is noted, OR if there are signs of fluid
    overload (pulmonary edema), Inotropic agents
    should be started.

75
Inotropic Agents
  • Dopamine Start infusion at 5 mcg/kg/min and
    titrate up to 20 mcg/kg/min in order to achieve
    desired BP
  • Indicated for reversing hypotension related to
    AMI, trauma, sepsis, heart failure, and renal
    failure when fluid resuscitation is unsuccessful
    or not appropriate (T. 212)

76
Inotropic Agents
  • Dobutamine Dosage range is 2 to 20 mcg/kg/min,
    however, most patients can be maintained at a
    rate of 10 mcg/kg/min
  • Indicated for cardiovascular decompensation due
    to ventricular dysfunction or low-output heart
    failure
  • Agent of choice for management of Cardiogenic
    Shock
  • Less effect on Heart Rate than Dopamine
  • (T. 212)

77
Inotropic Agents
  • Norepinephrine (Levophed) start infusion at 2
    mcg/min and titrate to achieve desired blood
    pressure.
  • Used when there is inadequate response to other
    pressors.
  • Lowest dosage that maintains BP should be used in
    order to minimize the complications of
    vasoconstriction
  • Increased survival rates of up to 40 in septic
    shock have been reported in the literature
  • (T. 246)

78
End Point of Resuscitation
  • Normalization of blood pressure, heart rate, and
    urine output
  • Goal is to maximize survival and minimize
    morbidity using objective hemodynamic and
    physiologic values to guide therapy

79
  • Questions ???
Write a Comment
User Comments (0)
About PowerShow.com